Вопросы современной педиатрии (Dec 2008)

EFFECTIVENESS AND SAFETY OF PIMECROLIMUS IN TREATMENT OF ATOPIC DERMATITIS IN CHILDREN AND ADOLESCENTS

  • K.N. Monakhov,
  • S.A. Ochelenko

Journal volume & issue
Vol. 7, no. 6
pp. 141 – 144

Abstract

Read online

The results of treatment of 57 patients with atopic dermatitis (ATD) in age 7–18 years old with elidel cream are described. Cream was drifted on facial skin 2 times daily. Apparent effect was marked on 7–14 day. There was no any case of serious adverse events. Thus, taking to account safety and effectiveness profile, pimecrolimus can be used as a medication of first line of therapy in treatment of ATD, while lesion is located on sensitive sectors of skin.Key words: children, atopic dermatitis, pimecrolimus.